I would think Woodford as a big BIO investor could easily afford to hire or contract good enough Medical professionals and Scientists to thoroughly validate any of NWBO's claims. I doubt he would've invested millions without doing so. Of course after reading your concerns I'm sure he will be loading up on PUTs come Monday.
Quote: "We need a big pharma partner. They would have the opportunity to thoroughly vet the ASCO data to their satisfaction and this would be a huge validation to NWBO if it occurs. I'm doubtful it will, but it would be a very very pleasant surprise."